BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Generic: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE is FDA application ANDA212678, sponsored by EDENBRIDGE PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of eze
Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was obse
Failed Impurities/Degradation Specifications
CGMP Deviations: Intermittent exposure to temperature excursion during storage.